ACADIA Pharmaceuticals Inc. - Common Stock — movimiento de fondos (NASDAQ:ACAD) | MetaTrader

Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas -136.17 M-125.66 M-114.03 M16.7 M157.72 M109.84 M 123.49 M Flujo de caja de las actividades de inversión 192.51 M-71.1 M73.24 M32 M-30.54 M-302.56 M -112.23 M Flujo de caja de las actividades financieras 81 M18.16 M8.2 M25.13 M6.84 M49.88 M 52.28 M Flujo de caja libre -136.17 M-125.66 M-114.03 M16.7 M157.72 M6.31 M 113.89 M

ACADIA Pharmaceuticals Inc. - Common Stock

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.

Noticias

Is MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh

MYGN Cancer Care Strategy: What's Driving 2026 Growth Plans

ACADIA Pharmaceuticals Inc. (ACAD) Presents at Bank of America Global Healthcare Conference 2026 Transcript

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Canaccord reitera su calificación de Acadia Pharmaceuticals tras los resultados del primer trimestre

ACADIA Pharmaceuticals presenta resultados: ¿pueden las ventas mantener el impulso?

Diapositivas del Q1 2026 de ACADIA: ingresos suben 11% pese a decepción en beneficios

Acadia Pharmaceuticals (ACAD) Lags Q1 Earnings and Revenue Estimates

ImmunityBio to Report Q1 Earnings: What's in the Cards?

IQVIA Set to Report Q1 Earnings: Here's What You Should Know

Guardian Pharmacy Services to Report Q1 Earnings: What's in the Cards?

CSLLY vs. ACAD: Which Stock Is the Better Value Option?